April 14, 2011 (London, Ontario) — A review of patients taking the diet drug orlistat (Xenical/Alli, Roche) in Ontario, Canada over a seven-year period points to a 2% increase in acute kidney injuries ...
A government committee of health experts yesterday opened the door to selling Orlistat, a prescription weight-loss drug in a reduced dosage directly to consumers. While the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback